In 104 premedicated patients undergoing general surgery, anaesthesia was induced either with etomidate 0.3 mg kg" 1 preceded by fentanyl 1.25 or 2.5 |*g kg" 1 i.v. or diazepam 0.0625 or 0.125 mg kg" 1 i.v., or with thiopentone preceded by fentanyl 1.25 y.g kg" 1 i.v. Despite the use of fentanyl or diazepam, the frequency of pain on injection in patients receiving etomidate was between 32% and 53%, being rated as severe in 5-20% of patients. No pain was experienced by patients receiving thiopentone. The frequency of involuntary movement was 15-35% with etomidate and 15% with thiopentone. The frequency of both pain and involuntary muscle movements was least when fentanyl 2.5 ng kg" 1 preceded the administration of etomidate. There was no significant relationship between the pain and muscle movement; three of 10 patients given etomidate into a central vein had such movements.
Pain during injection and involuntary muscle movement (Morgan, Lumley and Whitwam, 1975; Ghoneim and Yamada, 1977; Lees and Hendry, 1977; Schuermans et al., 1978) have restricted the popularity of etomidate as an i.v. anaesthetic agent. Fentanyl i.v. has been reported to alleviate the pain (Schuermans et al., 1978) , and oral diazepam to decrease the frequency of involuntary muscle movement (Holdcroft et al., 1976) . The use of polyethylene glycol or propylene glycol as a vehicle for etomidate has been reported also to produce less pain on injection than etomidate in an aqueous form (Van Dijk, 1978; Zacharias et al., 1978) .
We have compared etomidate dissolved in propylene glycol, preceded by fentanyl or diazepam administered i.v., with thiopentone as an induction agent for balanced general anaesthesia. Pain and involuntary muscle movements and changes in arterial pressure and heart rate during the induction period were recorded.
PATIENTS AND METHODS

Patients and anaesthesia
Eighty-four patients undergoing abdominal, urological or varicose vein surgery were studied. All were in good general health. According to the rating of Dundee, Moore and Nicholl (1962) , slight to moderate drowsiness was noted after premedication, which consisted of atropine 0.01 mg kg" 1 plus oxycodone chloride (Oxanest, Leiras, Turku) 0.13 mg kg" 1 , with promethazine chloride (Lergigan, Neofarma, Kuopio) 12.5-50 mg given i.m. 20 and 40-60 min before the induction of anaesthesia, respectively.
An i.v. cannula (Vygon, Paris, diameter 1.6 mm) was inserted into the largest forearm vein of all but two or three patients, in whom a vein in the dorsum of the hand was used. The injections of tubocurarine 3-5 mg (Tubocurarin, Orion, Helsinki) and fentanyl (Fentanyl, Orion, Helsinki) 1.25 or 2.5 [igkg-1 or diazepam (Diapam, Orion, Helsinki) 0.0625 or 0.125 mg kg" 1 were given i.v. over 30 s in a double-blind, randomized fashion (table I) . Two minutes later, anaesthesia was induced with etomidate dissolved in 35% propylene glycol (Etomidate 2 mg ml" 1 , Janssen, Beerse), 0.3 mg kg" 1 being injected in 30 s; tracheal intubation was facilitated with suxamethonium l.Smgkg" 1 (Sukolin, Orion, Helsinki); and anaesthesia was maintained with 66% nitrous oxide in oxygen given in a semi-open system with controlled ventilation. Minute volume was adjusted with the aid of an end-tidal carbon dioxide analyser to keep / > a COa in the normal range. Tubocurarine was given to maintain neuromuscular blockade; 20-25% of the patient's muscle power was maintained as assessed with a neurostimulator (Ali and Savarese, 1976) . Fentanyl was given to provide adequate analgesia. At the end of anaesthesia, atropine 1 mg and neostigmine 2 mg (Metastigmin, Star, Tampere) were given i.v. and the administration of nitrous oxide was stopped as soon as the patient recovered muscle power to the extent that train-of-four stimulae indicated no decrease in response (Ali and Savarese, 1976) . After wakening, the patients were transferred to the recovery room. Twenty patients with characteristics similar to those described above were premedicated and anaesthetized in the same manner, but fentanyl 1.25 [xg kg" 1 followed by thiopentone 3 mg kg" 1 was given for induction. All the i.v. injections were made into a rapidly running Ringer's lactate infusion solution (Fysiosol, Leiras, Turku). Informed consent was obtained from each patient for the procedure.
General assessment
Drowsiness was assessed 2 min after the injection of fentanyl or diazepam as follows: none = awake; slight = asleep, communicates easily; moderate = asleep, tries to communicate; severe = asleep, does not try to communicate.
Two minutes after the injection of etomidate or thiopentone, the eyelash reflex and reactions to surface pain (response to pinching lower abdomen with forceps) were tested. If the eyelash reflex was present and the anaesthetist considered the patient to be inadequately anaesthetized, etomidate 5 mg or thiopentone 50 mg was given before intubation.
Assessment of pain during injection and of involuntary muscle movements
The patients were asked during the injection of etomidate or thiopentone: "Do you feel something unusual in your arm ?" A burning sensation or pain was considered as slight pain. Grimacing or vocalization was rated as severe pain. Involuntary muscle movements during induction were rated none, slight, moderate (similar to suxamethonium-induced fasciculations), marked (need for restraint), severe (tonic or clonic convulsions).
The relationships between the degree of drowsiness, age and pain during injection and the frequency of involuntary movements were determined.
So that the frequency of muscle movements could be evaluated more accurately in patients not experiencing pain during the injection, another 10 patients with characteristics similar to the others were given etomidate 0.3 mg kg-1 into a central venous cannula without prior administration of fentanyl or diazepam.
Arterial pressure and heart rate
Systolic and diastolic arterial pressures were measured by auscultation (Chamberlain and Ogilvie, 1967) , and heart rate was recorded from an electrocardiographic monitor. Measurements were taken before the initial dose of tubocurarine, 2 min after the administration of fentanyl or diazepam (before the induction agent), 2 min after the injection of the etomidate or thiopentone, immediately after tracheal intubation, and before the incision.
General rating of anaesthesia
The quality of the anaesthesia was rated as poor, fair or good; the last rating represented smooth maintenance and rapid awakening.
Statistical analysis
Analysis of variance was used to compare arterial pressure and heart rate changes. Other assessments were compared with the Chi-square test because of the non-parametric nature of the data.
RESULTS
General assessment
Patients given diazepam were moderately to severely drowsy, whereas those receiving fentanyl were only slightly drowsy (P< 0.001; table II).
Assessments during the induction of anaesthesia and the frequency of additional doses of etomidate or thiopentone are shown in table III. The eyelash reflex was present more often (P<0.01) after the smaller dose of fentanyl than after diazepam. Reactions to abdominal pinching were most frequent after thiopentone. Patients tolerated the presence of the endotracheal tube best (77%) when fentanyl 2.5 (ig kg" 1 was given before the etomidate and worst (15%) when diazepam 0.0625 mg kg" 1 was given before etomidate. None of the patients given the larger doses of fentanyl or diazepam needed more than the initial 0.3 mg kg" 1 of etomidate before intubation, while three patients who were given the smaller dose of fentanyl and one patient who was given the smaller dose of diazepam needed more. However, eight patients (40%) who were given the 3-mg kg" 1 dose of thiopentone after fentanyl 1.25 y.g kg" 1 needed more thiopentone to induce sleep.
Pain and involuntary muscle movements
None of the patients receiving thiopentone reported pain during its injection, while 32-53% of the patients given etomidate did so (/ 3 <0.01). The nature of pain was generally slight, but depending on the preceding adjuvant, it was rated as severe by 5-20% of the patients (table IV) .
Involuntary muscle movements were commonest in patients who received diazepam before etomidate (29-35%), and in 5% of all the patients given etomidate, the movements were severe and required restraint.
No significant relationships were noticed between the patient's degree of drowsiness, age, or the frequency of pain during the injection and the frequency of involuntary muscle movements (table  V) . However, such movements were twice as common in patients slightly or moderately drowsy, in those patients under the age of 60 yr or in patients who reported pain during the injection, compared with those patients who were more drowsy, who were older or who did not feel pain during the injection.
Three out of the 10 patients who were given etomidate 0.3 mg kg" 1 into a central vein had involuntary muscle movements without any feelings of pain during injection. In one of the patients, the movements were rated as severe.
TABLE V. Relationship of drowsiness, age and pain during the injection to the frequency of involuntary muscle movements in patients injected with etomidate (n = 84)
Arterial pressure and heart rate There were no significant differences between the groups in systolic arterial pressure when measured after the injection of diazepam or fentanyl, after the induction agent, or before the incision ( fig. 1 ). The increase in systolic arterial pressure following intubation differed significantly (P<0.01) between the groups. The increase averaged 25 mm Hg in patients given the smaller dose of fentanyl before etomidate or thiopentone; it averaged less than half that in those patients given the larger dose of diazepam before No. of Movements etomidate. The changes in heart rate and diastolic Variable patients (%) arterial pressure resembled the changes in systolic arterial pressure ( fig. 1 ).
General acceptability of anaesthesia
On the anaesthetist's rating of the quality of anaesthesia (table VI), there were no differences for these variables between groups.
The commonest reasons for not rating these variables as good were: (1) induction: pain or involuntary movements with etomidate; need to give more induction agent with thiopentone; (2) maintenance: greater than usual need to supplement nitrous oxide with either etomidate or thiopentone; involuntary muscle movements with etomidate; (3) awakening: delayed. Awakening was delayed and drowsiness in recovery room greatest in patients receiving diazepam 0.125 mg kg" 1 before etomidate.
DISCUSSION
The use of fentanyl or diazepam before etomidate did not prevent pain during its injection or involuntary muscle movement, although these reactions were generally mild and the quality of induction broadly comparable to that of thiopentone. With these drug combinations, the changes in arterial pressure and heart rate after etomidate were similar to those after thiopentone.
Since an unacceptable high frequency of pain on injection and involuntary muscle movement has been noticed with etomidate alone (Holdcroft et al., 1976; Schuermans et al., 1978; Zacharias et al., 1978) , this was not given. It has been suggested (Morgan, Lumley and Whitwam, 1975; Holdcroft et al., 1976; Ghoneim and Yamada, 1977; Zacharias et al., 1978 ) that etomidate 0.3 mg kg" 1 would be sufficient for the induction of anaesthesia and approximately equivalent to thiopentone 3 mg kg"
1 . However, our finding that 40% of the patients receiving thiopentone 3 mg kg" 1 after fentanyl needed additional doses to induce sleep, compared with only 14% of the patients given etomidate 0.3 mg kg"
1 after fentanyl, indicates that a 4-mg kg" 1 dose of thiopentone might have been preferable.
The doses of fentanyl used were based on a recent recommendation by Doenicke (1978) , and those of diazepam on the findings of Korttila and Linnoila (1975) and Korttila and others (1978) .
Pain and involuntary muscle movements
When dissolved in water, etomidate caused pain on injection in 15% (Morgan, Lumley and Whitwam, 1975) to 50% (Zacharias et al., 1978) of patients. In propylene glycol solvent, pain occurred in 25-35% with excitatory phenomena in 85-95% of unpremedicated patients (Zacharias et al., 1978) . Doenicke and colleagues (1973) noticed fewer muscle movements in healthy volunteers receiving diazepam 0.1 mg kg" 1 i.v. before etomidate. In our study, the frequency of pain on injection (32-53%) occurred despite opiate-promethazine premedication and i.v. fentanyl or diazepam before the etomidate. Because patients were questioned as to whether they felt something unusual in their arms, rather than waiting for them to volunteer this information, the frequency of such a side-effect (severe in 5-20%) is likely to be greater than that reported by other workers. Ghoneim and Yamada (1977) noticed a significant association between pain and movements, but Van Dijk (1978) and Zacharias and colleagues (1978) did not. In our study, movements were twice as frequent in patients with pain on injection than in those without pain, but the occurrence of movements during the administration of etomidate into a central vein suggests that pain on injection is not the only explanation for these excitatory phenomena.
Cardiovascular effects
Etomidate alone has been reported to have only minor haemodynamic effects (Bruckner et al., 1974; Doenicke et al,, 1974; Hempelmann et al., 1974; Patschke et al., 1977) . The combination of etomidate with diazepam and fentanyl was associated with cardiovascular stability similar to that of thiopentone. An index of myocardial oxygen demand can be obtained by the product of the arterial pressure and heart rate (Robinson, 1967; Kaplan, Dunbar and Jones, 1976) . If this rate/pressure product is used, it would appear that either fentanyl 0.2 mg or diazepam 5-10 mg given before etomidate may decrease the risks associated with the cardiovascular response to laryngoscopy and endotracheal intubation.
CONCLUSIONS
Pain on injection and excitatory phenomena were still unacceptably severe in 5% of the patients given i.v. fentanyl 2. 
